Picture of Xylo Technologies logo

XYLO Xylo Technologies Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapValue Trap

Annual cashflow statement for Xylo Technologies, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARS20-F20-F20-F20-F
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-14.2-6.844.15-10.1-21.8
Depreciation
Non-Cash Items10.10.687-9.642.1511.9
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital1.28-0.156-0.083-0.946-0.285
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Change in Payable / Accrued Expenses
Change in Taxes Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities-2.69-6.14-5.25-5.66-6.25
Capital Expenditures-0.062-0.324-5.14-0.074-1.75
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items-4.06-1.28-7.3-4.40.309
Acquisition of Business
Sale of Business
Sale/Maturity of Investment
Change in Net Investments
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities-4.12-1.6-12.4-4.48-1.44
Financing Cash Flow Items3.21.920-3.35
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities3.1622.919.15.41-3.15
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-3.5915.31.66-3.96-10.7